These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 773412)

  • 1. The clinical assessment of topical corticosteroid activity.
    Wilson L
    Br J Dermatol; 1976 Mar; 94 suppl 12():33-42. PubMed ID: 773412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
    WILLIAMS DI; WILKINSON DS; OVERTON J; MILNE JA; MCKENNA WB; LYELL A; CHURCH R
    Lancet; 1964 May; 1(7344):1177-9. PubMed ID: 14132653
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical corticosteroids for skin disorders.
    Med Lett Drugs Ther; 1966 May; 8(10):37-8. PubMed ID: 4223426
    [No Abstract]   [Full Text] [Related]  

  • 4. Tibicorten and betamethasone valerate: a double-blind comparative study.
    Tazelaar DJ
    J Int Med Res; 1977; 5(5):338-45. PubMed ID: 334605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARATIVE EFFECTS OF CURRENT TOPICAL CORTICOSTEROIDS.
    EDELSTEIN AJ
    Arch Dermatol; 1964 Mar; 89():393-4. PubMed ID: 14096359
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative double-blind clinical trial of fluocinonide and betamethasone valerate.
    Sarkany I
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):70-1. PubMed ID: 4947904
    [No Abstract]   [Full Text] [Related]  

  • 7. "Metosyn" in psoriasis and eczema.
    Portnoy B; Sarkany I
    Br J Dermatol; 1972 Mar; 86(3):310-1. PubMed ID: 4553161
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
    Afzelius HW; Jacobsen KU
    J Int Med Res; 1979; 7(5):411-4. PubMed ID: 387495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TREATMENT OF PSORIASIS WITH WET OCCLUSIVE DRESSING].
    KONIA H
    Dermatologica; 1964; 129():47-56. PubMed ID: 14181377
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of localized skin lesions with betamethasone 17-valerate and triamcinolone acetonide in alcoholic solution under occlusive dressing. A double blind comparative study.
    Neering H; van der Kroon HV; Roeleveld CG
    Dermatologica; 1972; 145(6):395-9. PubMed ID: 4571883
    [No Abstract]   [Full Text] [Related]  

  • 11. DOUBLE-BLIND COMPARATIVE TRIAL OF BETAMETHASONE 17-VALERATE AND FLUOCINOLONE ACETONIDE OINTMENTS.
    BUCKLEY DB
    J Ir Med Assoc; 1964 Aug; 55():45-7. PubMed ID: 14179703
    [No Abstract]   [Full Text] [Related]  

  • 12. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betamethasone 17-valerate ointment in a lanolin-free base.
    Wilson L
    Curr Med Res Opin; 1973; 1(4):228-32. PubMed ID: 4589630
    [No Abstract]   [Full Text] [Related]  

  • 14. BETAMETHASONE 17-VALERATE: A CLINICAL TRIAL OF A NEW TOPICAL STEROID.
    MITCHELL DM; HEANY SH; EAKINS TS
    J Ir Med Assoc; 1964 Aug; 55():44-5. PubMed ID: 14179702
    [No Abstract]   [Full Text] [Related]  

  • 15. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB; Gregory JF; Bartruff JK
    South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical evaluation of a new topical corticosteroid, clobetasol propionate. An international controlled trial.
    Sparkes CG; Wilson L
    Br J Dermatol; 1974 Feb; 90(2):197-203. PubMed ID: 4594577
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of fluocinonide and betamethasone in the treatment of psoriasis and eczema.
    Portnoy B
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):72-3. PubMed ID: 5291636
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer topical therapy in dermatology.
    Bluefarb SM
    Int J Dermatol; 1970; 9(3):200-8. PubMed ID: 5476381
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function.
    Scoggins RB; Kliman B
    J Invest Dermatol; 1965 Nov; 45(5):347-55. PubMed ID: 5321337
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the base on the results of clinical trials with topical corticosteroids.
    Vollum DI; Sparkes CG
    Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.